Transcranial Direct Current Stimulation in Stroke Rehabilitation

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

34 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-03-31

Study Completion Date

2011-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study investigates if transcranial Direct Current Stimulation (tDCS) is effective in the recovery of postural control in stroke rehabilitation.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effect of tDCS on Brain Organization and Motor Recovery

NCT03342534

Stroke

TERMINATED NA

Stroke Treatment Associate to Rehabilitation Therapy and Transcranial DC Stimulation

NCT02156635

Stroke Cerebrovascular Disorders Cerebral Infarction

UNKNOWN PHASE2/PHASE3

tDCS in Poststroke on Upper Limb Rehabilitation

NCT02166619

Stroke

UNKNOWN PHASE2

The Influence of tDCS on the Arm and Hand Function in Stroke Patients

NCT02210403

Transcranial Direct Current Stimulation Cerebrovascular Accident (CVA)

COMPLETED NA

Multicenter Study on the Efficacy of Transcranial Direct Current Stimulation (tDCS) in Post-stroke Motor Recovery

NCT04166968

Stroke, Ischemic Stroke Hemorrhagic

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The patients were divided in 2 groups by a randomisation procedure. All patients participated for 2 months in the study. Group 1 received true tDCS in the first month followed by SHAM stimulation in the second month. Group 2 received SHAM in the first month and true stimulation in the following month. Four stimulations of 20minutes were provided during 4 weeks before before changing stimulation intensity.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

SHAM TDCS

Group Type SHAM_COMPARATOR

Application of Transcranial direct current stimulation (TDCS)

Intervention Type DEVICE

Application of TDCS for 20 minutes, 4 times a week for 4 weeks.

True TDCS

Group Type ACTIVE_COMPARATOR

Transcranial Direct current stimulation

Intervention Type DEVICE

Application of true TDCS for 20min, 4 times a week for 4 weeks.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Application of Transcranial direct current stimulation (TDCS)

Application of TDCS for 20 minutes, 4 times a week for 4 weeks.

Intervention Type DEVICE

Transcranial Direct current stimulation

Application of true TDCS for 20min, 4 times a week for 4 weeks.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

tDCS device: CESta, Mind Alive Inc.,Edmonton, Alberta, Canada tDCS device: CESta, Mind Alive Inc., Edmonton, Alberta, Canada

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patients suffering from the consequences of a stroke in the medial cerebral artery, during the sub-acute phase (4-24 weeks after onset)
2. Age between 18-75 years
3. Hospitalised in rehabilitation Hospital Hof Ter Schelde
4. Capable of understanding and giving informed consent

Exclusion Criteria

1. Cerebellum or brainstem lesions
2. Recently multiple lesions and older lesions which are manifested clinically.
3. History of severe substance abuse (alcohol, drugs, benzodiazepines)
4. Cardiac disease that in the opinion of the clinician precludes participation in the trial (severe dyspnea in rest, severe rhythm disturbances, etc)
5. History of epileptic insults, not caused by the stroke
6. Severe organic co morbidity
7. Psychiatric disorders or history of psychiatric disorders
8. Pace maker / internal defibrillator
9. Pregnancy

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No